Kindyk (688670): The quadrivalent influenza vaccine ushered in an opportunity to be released, and the second half of the year is worth looking forward to
國海證券Aug 8, 2022 00:00
Kindyk (688670): Performance growth is limited due to the impact of the epidemic and I am optimistic about influenza vaccine release in the third and fourth quarter
華安證券May 7, 2022 00:00
Kindick (688670) Annual report comments: short-term performance under pressure in the orderly progress of the pipeline
國金證券Apr 10, 2022 00:00
Kindick (688670): rapid growth of tetravalent Influenza Vaccine
天風證券Oct 18, 2021 00:00
Kindick (688670): the performance is in line with expectations and continues to increase the volume of tetravalent influenza vaccine.
太平洋證券Oct 18, 2021 00:00
Kindick (688670): rapid growth in performance and steady improvement in profitability
國金證券Oct 18, 2021 00:00
Kindyk (688670): Employee equity incentives enhance cohesion, long-term performance development can be expected
天風證券Aug 28, 2021 00:00
金迪克:四价流感疫苗高速增长,新建产能奠定业绩增长基础
天风国际Aug 12, 2021 09:31
Kindick (688670) first coverage report: rapid growth of new production capacity of tetravalent influenza vaccine lays the foundation for performance growth
天風證券Aug 10, 2021 00:00
No Data
No Data